Hamilelikte methyl morpholine oxide kullanmaktan kaçınmalı mıyım? | VeriMom
ECHA lists 4‑methylmorpholine 4‑oxide (N‑methylmorpholine N‑oxide; CAS 7529‑22‑8) with a harmonised CLP reproductive hazard H361f (suspected of damaging fertility), which supports a suspected reproductive hazard (h=2). A specific molecular mechanism for reproductive effects is not described in available dossiers, so mechanism is scored as theoretical/uncertain (m=1). For typical topical cosmetic use dermal exposure is low but measurable (hydrophilic substance, low logP), so adult exposure is scored low (e=1). Sources: ECHA classification and supplier/MSDS listings.
ECHA regulatory hazard statements
- •H361
- •H361F
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- methyl morpholine oxide hamilelikte güvenli mi?
- ECHA lists 4‑methylmorpholine 4‑oxide (N‑methylmorpholine N‑oxide; CAS 7529‑22‑8) with a harmonised CLP reproductive hazard H361f (suspected of damaging fertility), which supports a suspected reproductive hazard (h=2). A specific molecular mechanism for reproductive effects is not described in available dossiers, so mechanism is scored as theoretical/uncertain (m=1). For typical topical cosmetic use dermal exposure is low but measurable (hydrophilic substance, low logP), so adult exposure is scored low (e=1). Sources: ECHA classification and supplier/MSDS listings.
- methyl morpholine oxide emzirirken güvenli mi?
- Harmonised H361f (ECHA) applies to general reproductive/fertility concern and is the principal driver (h=2). No clear data on mammary/milk transfer or neonatal toxicity were found; mechanism remains uncharacterized (m=1). Given the compound's hydrophilicity and expected low dermal/systemic absorption from cosmetics, exposure via topical maternal use is judged low (e=1), but milk transfer data are lacking.
- methyl morpholine oxide bebek cildi için güvenli mi?
- Hazard remains driven by harmonised H361f → h=2. Mechanistic evidence is lacking (m=1). Because infant skin (0–3 yr) has higher surface‑area‑to‑weight and an immature barrier, exposure score is increased by +1 compared with adult (adult e=1 → baby e=2) where measurable dermal absorption is plausible. No infant‑specific toxicity or exposure studies were found.
- VeriMom methyl morpholine oxide nasıl puanlıyor?
- VeriMom methyl morpholine oxide'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 27/100 (yüksek risk) olarak puanlar.
- Hamilelikte methyl morpholine oxide yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.